HADH Antibody (4B5)

This product is produced by and distributed for Abnova, a company based in Taiwan.

This gene is a member of the 3-hydroxyacyl-CoA dehydrogenase gene family. The encoded protein functions in the mitochondrial matrix to catalyze the oxidation of straight-chain 3-hydroxyacyl-CoAs as part of the beta-oxidation pathway. Its enzymatic activity is highest with medium-chain-length fatty acids. Mutations in this gene cause one form of familial hyperinsulinemic hypoglycemia. The human genome contains a related pseudogene.

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Showing Publications 1 - 4 of 4.

Publications using H00003033-M01	Applications	Species
Nordby P, Rosenkilde M, Ploug T et al. Independent effects of endurance training and weight loss on peak fat oxidation in moderately overweight men: a randomized controlled trial. J Appl Physiol (1985). 2015-04-01 [PMID: 25614598]
Rosenkilde M, Reichkendler MH, Auerbach P et al. Changes in peak fat oxidation in response to different doses of endurance training. Scand J Med Sci Sports. 2013-12-18 [PMID: 24350597]
Tonjes M, Barbus S, Park YJ et al. BCAT1 promotes cell proliferation through amino acid catabolism in gliomas carrying wild-type IDH1. Nat Med. 2013-06-23 [PMID: 23793099]
Halbert D, Domenyuk V, Spetzler D et al. Aptamers and uses thereof United States Patent Application US 9958448 B2 2018-01-01

Array H00003033-M01

• HADH Antibodies
• HADH Lysate
• HADH Proteins